Literature DB >> 16871229

Naked plasmid DNA transfer to the porcine liver using rapid injection with large volume.

H Yoshino1, K Hashizume, E Kobayashi.   

Abstract

The naked plasmid DNA transfer method of rapid injection with large volume has been useful for gene therapy in experimental study. However, only small animals like rodents have usually been reported on. In this study, the authors attempted to transfect naked plasmid DNA to the porcine liver by modified hydrodynamic method. We decided to transfer plasmid DNA to a part of the liver using the angio-catheter to reduce the liver damage. To discern the condition of injection, naked plasmid DNA-encoding green fluorescent protein (GFP) was transferred for use as a marker gene. The GFP gene expression was markedly observed in gene-transferred pig livers. In large animals, not only the naked gene quantity, the solution volume containing the plasmid DNA and the injection speed, but also the additional treatments of the portal vein and the hepatic artery preparation were crucial. We found that the following injection condition were needed: plasmid DNA, 3 mg; the solution volume, 150 ml and the injection speed, 5 ml/s. The portal vein and the hepatic artery were clamped during gene delivery and the blood flow of the portal vein was flushed out using normal saline. Cytotoxic T-lymphocyte antigen 4-immunoglobulin (CTLA4-Ig) gene was used to test for secretory protein. CTLA4-Ig gene was injected with a large volume of solution via the hepatic vein to the left outer lobe of the liver selectively. CTLA4-Ig was detected in the pig blood at a maximum serum level of 161.7 ng/ml 1 day after gene transfer, and the CTLA4-Ig was detected for several weeks. Our new technique of inserting a catheter into only a selected portion of the liver reduced liver toxicity and increased gene transfer efficiency. This is the first report of successful gene transfer, using a hydrodynamic method, to the segmental liver in pigs, and achieved more than enough secretory protein for the clinically therapeutic level in pigs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16871229     DOI: 10.1038/sj.gt.3302833

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  43 in total

Review 1.  Nonviral gene delivery: what we know and what is next.

Authors:  Xiang Gao; Keun-Sik Kim; Dexi Liu
Journal:  AAPS J       Date:  2007-03-23       Impact factor: 4.009

2.  Prolongation of heart allograft survival after long-term expression of soluble MHC class I antigens and vIL-10 in the liver by AAV-plasmid-mediated gene transfer.

Authors:  A Doenecke; E Frank; M N Scherer; H-J Schlitt; E K Geissler
Journal:  Langenbecks Arch Surg       Date:  2008-03-06       Impact factor: 3.445

Review 3.  Efficacy and safety of Sleeping Beauty transposon-mediated gene transfer in preclinical animal studies.

Authors:  Perry B Hackett; Elena L Aronovich; David Hunter; Myra Urness; Jason B Bell; Steven J Kass; Laurence J N Cooper; Scott McIvor
Journal:  Curr Gene Ther       Date:  2011-10       Impact factor: 4.391

Review 4.  The Sleeping Beauty transposon system: a non-viral vector for gene therapy.

Authors:  Elena L Aronovich; R Scott McIvor; Perry B Hackett
Journal:  Hum Mol Genet       Date:  2011-04-01       Impact factor: 6.150

5.  Transgene Expression in Dogs After Liver-Directed Hydrodynamic Delivery of Sleeping Beauty Transposons Using Balloon Catheters.

Authors:  Kendra A Hyland; Elena L Aronovich; Erik R Olson; Jason B Bell; Myra Urness Rusten; Roland Gunther; David W Hunter; Perry B Hackett; R Scott McIvor
Journal:  Hum Gene Ther       Date:  2017-04-19       Impact factor: 5.695

6.  α-1-antitrypsin gene delivery reduces inflammation, increases T-regulatory cell population size and prevents islet allograft rejection.

Authors:  Galit Shahaf; Hadas Moser; Eyal Ozeri; Mark Mizrahi; Avishag Abecassis; Eli C Lewis
Journal:  Mol Med       Date:  2011-06-09       Impact factor: 6.354

7.  Human AAT gene transfer to pig liver improved by using a perfusion isolated organ endovascular procedure.

Authors:  Luis Sendra; Daniel Pérez; Antonio Miguel; María José Herrero; Inmaculada Noguera; Ana Díaz; Domingo Barettino; Luis Martí-Bonmatí; Salvador F Aliño
Journal:  Eur Radiol       Date:  2015-04-25       Impact factor: 5.315

8.  Phenotypic correction of ornithine transcarbamylase deficiency using low dose helper-dependent adenoviral vectors.

Authors:  Nicola Brunetti-Pierri; Christian Clarke; Viraj Mane; Donna J Palmer; Brendan Lanpher; Qin Sun; William O'Brien; Brendan Lee
Journal:  J Gene Med       Date:  2008-08       Impact factor: 4.565

Review 9.  The role of liver sinusoidal cells in hepatocyte-directed gene transfer.

Authors:  Frank Jacobs; Eddie Wisse; Bart De Geest
Journal:  Am J Pathol       Date:  2009-11-30       Impact factor: 4.307

10.  Effect of nuclear localization and hydrodynamic delivery-induced cell division on phiC31 integrase activity.

Authors:  L E Woodard; R T Hillman; A Keravala; S Lee; M P Calos
Journal:  Gene Ther       Date:  2009-10-22       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.